Data Foundry

Drug recalls 2013

DOBUTamine in 5% Dextrose Injection — Class II drug recall D-502-2013

Terminated recall by Hospira Inc., reported 2013-06-12, distributed nationwide. Lack of Assurance of Sterility: Confirmed report of leaking in the primary container.

Recall numberD-502-2013
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmHospira Inc., Lake Forest, IL, United States
Recall initiated2013-04-30
Classified2013-06-03
Reported by FDA2013-06-12
Terminated2014-10-08
DistributedNationwide (US)
Quantity44,748 bags
Reason classessterility, packaging
NDC00409-2346-32
Lot numbers11-309-KL

Product

DOBUTamine in 5% Dextrose Injection, USP, 250 mg Total, 1000 mcg/mL 250 mL bag, Rx only, HOPIRA, INC., LAKE FOREST, IL 60045 NDC 0409-2346-32

Reason for recall

Lack of Assurance of Sterility: Confirmed report of leaking in the primary container.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-502-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-10. Not affiliated with or endorsed by FDA. Not medical or legal advice.